Literature DB >> 20644271

A clinicopathological and immunohistochemical study of clinically non-functioning pituitary adenomas: a single institutional experience.

Arvind Rishi1, Mehar C Sharma, Chitra Sarkar, Deepali Jain, Manmohan Singh, Ashok Kumar Mahapatra, Veer Singh Mehta, Tapos Kumar Das.   

Abstract

BACKGROUND: Non-functioning pituitary adenomas (NFPA) are characterized by the lack of clinical syndrome as compared to functioning adenomas (FA) but not all functioning adenomas have clinical effects. Their exact incidence varies in different series.
MATERIALS AND METHODS: This study was undertaken to analyze the hormonal profile of NFPA at the immunohistochemical level in the Indian population and to see if any differences exist from the earlier studies. Their biological aggressiveness was also studied by MIB-1 labeling index (MIB-! LI) and Epidermal Growth Factor Receptor (EGFR) expression. These parameters along with their clinical behavior were correlated with radiological features of invasiveness and size.
RESULTS: Of the 151 pituitary adenomas diagnosed during a period of one and half years, 77 (51%) were NFPA with a male predominance. There was increase in the incidence of NFPA with increase in age. Immunopositivity for various hormones was observed in 64 (83%) cases, either singly or in various combinations. On the basis of immunohistochemistry, NFPA were classified into three subtypes; gonadotroph adenomas, silent adenomas, and null cell adenomas. Gonadotroph adenomas were the commonest subtype. In general, NFPA showed low MIB-1LI but invasive NFPA had LI on the higher side, however, this difference was not significant. We observed EGFR positivity in two cases only; therefore the tumorigenesis mechanism may be different in NFPA.
CONCLUSION: Although non-functional at the clinical level immunohistochemistry showed reactivity for various hormones. If a battery of immunostains including seven hormones is studied, a significant number of cases are shifted to the functional group.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20644271     DOI: 10.4103/0028-3886.66336

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  7 in total

Review 1.  Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review.

Authors:  Sabrina Chiloiro; Antonio Bianchi; Francesco Doglietto; Chiara de Waure; Antonella Giampietro; Alessandra Fusco; Donato Iacovazzo; Linda Tartaglione; Francesco Di Nardo; Francesco Signorelli; Libero Lauriola; Carmelo Anile; Guido Rindi; Giulio Maira; Alfredo Pontecorvi; Laura De Marinis
Journal:  Pituitary       Date:  2014-06       Impact factor: 4.107

Review 2.  PI3K/Akt/mTOR and Raf/MEK/ERK signaling pathways perturbations in non-functioning pituitary adenomas.

Authors:  Hadara Rubinfeld; Ilan Shimon
Journal:  Endocrine       Date:  2012-05-03       Impact factor: 3.633

3.  Nucleostemin and ASPP2 expression is correlated with pituitary adenoma proliferation.

Authors:  Lin Ma; Zhi-Min Chen; Xue-Yuan Li; Xin-Jun Wang; Ji-Xin Shou; Xu-Dong Fu
Journal:  Oncol Lett       Date:  2013-09-04       Impact factor: 2.967

4.  Cytohistological correlation in pituitary tumor and immunological assessment with the help of Ki-67.

Authors:  A Sen; C Das; M Mukhopadhyay; S Mukhopadhyay; S Deb; B Mukhopadhyay
Journal:  J Postgrad Med       Date:  2017 Apr-Jun       Impact factor: 1.476

5.  Microarray technology reveals potentially novel genes and pathways involved in non-functioning pituitary adenomas.

Authors:  X Qiao; H Wang; X Wang; B Zhao; J Liu
Journal:  Balkan J Med Genet       Date:  2017-03-09       Impact factor: 0.519

6.  Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers.

Authors:  Anna S Berghoff; Harald Stefanits; Adelheid Woehrer; Harald Heinzl; Matthias Preusser; Johannes A Hainfellner
Journal:  Clin Neuropathol       Date:  2013 May-Jun       Impact factor: 1.368

7.  A novel "total pituitary hormone index" as an indicator of postoperative pituitary function in patients undergoing resection of pituitary adenomas.

Authors:  Shousen Wang; Biao Li; Chenyu Ding; Deyong Xiao; Liangfeng Wei
Journal:  Oncotarget       Date:  2017-03-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.